Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 05/02/2012 - 05/02/2015

This course is closed. Please look for other available products in CPNP University.

Session Summary

The deinstitutionalization of psychiatric facilities has been a major factor that has led to the current crisis of the criminalization of the mentally ill.  Judge Steven Leifman, a Miami-Dade County Judge who has also served as Special Advisor on Criminal Justice and Mental Health for the Supreme Court of Florida, is responsible for chairing the Court’s Mental Health Subcommittee.  He and his group authored a ground-breaking report entitled, Transforming Florida’s Mental Health System.

During his presentation, Judge Leifman will discuss new and effective strategies that are being developed and employed to transform the mental health system.  He will address ways that providers can assist those with mental health disorders to maneuver the criminal justice system to minimize burden.  Additionally, he will discuss how pharmacists and other health care professionals can get involved in a legislative manner to help transform the mental health system.

Listen to NPR Interview with Judge Leifman

 

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This session was presented live at the 2012 CPNP Annual Meeting. A PDF file of the slides and audio of the speaker’s presentation is provided. ACPE transcripts can be retrieved by participants online at cpnp.org and the credit will be automatically submitted to your account at CPE Monitor shortly after the evaluation is completed.

Faculty Information and Disclosures

Learning Objectives

  1. Describe the "deinstitutionalization" of psychiatric facilities and summarize how it has led to the criminalization of mental illness.
  2. Discuss how the justice system has responded to the crisis of the criminalization of people with mental illnesses
  3. Discuss new and effective strategies that are being developed and employed to transform the mental health system.
  4. Formulate ways that providers can assist those with mental health disorders to maneuver the criminal justice system to minimize burden.
  5. Discuss how pharmacists can get involved in a legislative manner to help transform the mental health system.

Continuing Education Credit and Disclosures

Activity Dates: 05/02/2012 - 05/02/2015
ACPE Contact Hours: 1.0
ACPE Number: 0284-9999-12-021-H04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPE Credit

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

CME Credit

Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. ACCME credit is no longer available for this course.

Nursing Credit

ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website):  “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.

Grant Support

Annual Meeting Grant Supporter

Cyberonics

Genentech